Back to Search Start Over

Biological differences between FIM2 and FIM3 fimbriae of Bordetella pertussis: not just the serotype

Authors :
Soraya Matczak
Valérie Bouchez
Pauline Leroux
Thibaut Douché
Nils Collinet
Annie Landier
Quentin Giai Gianetto
Sophie Guillot
Julia Chamot-Rooke
Milena Hasan
Mariette Matondo
Sylvain Brisse
Julie Toubiana
Biodiversité et Epidémiologie des Bactéries pathogènes - Biodiversity and Epidemiology of Bacterial Pathogens
Institut Pasteur [Paris] (IP)-Université Paris Cité (UPCité)
Plateforme de Protéomique / Proteomics platform
Université Paris Cité (UPCité)-Spectrométrie de Masse pour la Biologie – Mass Spectrometry for Biology (UTechS MSBio)
Institut Pasteur [Paris] (IP)-Institut de Chimie du CNRS (INC)-Centre National de la Recherche Scientifique (CNRS)-Université Paris Cité (UPCité)-Institut Pasteur [Paris] (IP)-Institut de Chimie du CNRS (INC)-Centre National de la Recherche Scientifique (CNRS)
Centre national de Référence de la Coqueluche et autres Bordetelloses - National Reference Center for Whooping Cough and other Bordetella infections (CNR)
Hub Bioinformatique et Biostatistique - Bioinformatics and Biostatistics HUB
Spectrométrie de Masse pour la Biologie – Mass Spectrometry for Biology (UTechS MSBio)
Institut Pasteur [Paris] (IP)-Institut de Chimie du CNRS (INC)-Centre National de la Recherche Scientifique (CNRS)-Université Paris Cité (UPCité)
Cytometrie et Biomarqueurs – Cytometry and Biomarkers (UTechS CB)
Département de Pédiatrie et maladies infectieuses [CHU Necker]
CHU Necker - Enfants Malades [AP-HP]
Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)
JT received funding from Ville de Paris as part of the EMERGENCE program. SM received funding from la Fondation pour la Recherche Médicale (FRM). SB received funding from INCEPTION program (ANR-16-CONV-0005).
ANR-16-CONV-0005,INCEPTION,Institut Convergences pour l'étude de l'Emergence des Pathologies au Travers des Individus et des populatiONs(2016)
Source :
Microbes and Infection, Microbes and Infection, 2023, pp.105152. ⟨10.1016/j.micinf.2023.105152⟩
Publication Year :
2023
Publisher :
Elsevier BV, 2023.

Abstract

International audience; Introduction: Bordetella pertussis still circulates worldwide despite vaccination. Fimbriae are components of some acellular pertussis vaccines. Population fluctuations of B. pertussis fimbrial serotypes (FIM2 and FIM3) are observed, and fim3 alleles (fim3-1 [clade 1] and fim3-2 [clade 2]) mark a major phylogenetic subdivision of B. pertussis. Objectives: To compare microbiological characteristics and expressed protein profiles between fimbrial serotypes FIM2 and FIM3 and genomic clades. Methods: A total of 23 isolates were selected. Absolute protein abundance of the main virulence factors, autoagglutination and biofilm formation, bacterial survival in whole blood, induced blood cell cytokine secretion, and global proteome profiles were assessed. Results: Compared to FIM3, FIM2 isolates produced more fimbriae, less cellular pertussis toxin subunit 1 and more biofilm, but auto-agglutinated less. FIM2 isolates had a lower survival rate in cord blood, but induced higher levels of IL-4, IL-8 and IL-1 secretion. Global proteomecomparisons uncovered 15 differentially produced proteins between FIM2 and FIM3 isolates, involved in adhesion and metabolism of metals. FIM3 isolates of clade 2 produced more FIM3 and more biofilm compared to clade 1. Conclusion: FIM serotype and fim3 clades are associated with proteomic and other biological differences, which may have implications on pathogenesis and epidemiological emergence.

Details

ISSN :
12864579
Database :
OpenAIRE
Journal :
Microbes and Infection
Accession number :
edsair.doi.dedup.....9e496bfec6638b3e6cd008db37d44ea9
Full Text :
https://doi.org/10.1016/j.micinf.2023.105152